|
COPS5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.169700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.766200E-02 |
| Normal-vs-Stage2 |
7.415000E-01 |
| Normal-vs-Stage3 |
6.521400E-01 |
| Normal-vs-Stage4 |
7.505800E-02 |
| Stage1-vs-Stage2 |
1.154850E-01 |
| Stage1-vs-Stage3 |
3.227200E-01 |
| Stage1-vs-Stage4 |
2.600500E-02 |
| Stage2-vs-Stage3 |
5.400000E-01 |
| Stage2-vs-Stage4 |
3.672000E-01 |
| Stage3-vs-Stage4 |
1.310950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.002400E-02 |
| Normal-vs-AfricanAmerican |
5.020000E-01 |
| Normal-vs-Asian |
5.041800E-01 |
| Caucasian-vs-AfricanAmerican |
2.637000E-01 |
| Caucasian-vs-Asian |
2.451600E-01 |
| AfricanAmerican-vs-Asian |
4.890400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.956100E-02 |
| Normal-vs-Female |
2.584200E-01 |
| Male-vs-Female |
3.219200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.565820E-01 |
| Normal-vs-Extreme_Weight |
1.919020E-01 |
| Normal-vs-Obese |
7.939900E-02 |
| Normal-vs-Extreme_Obese |
7.216400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.592400E-01 |
| Normal_Weight-vs-Obese |
9.122400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.944800E-01 |
| Extreme_Weight-vs-Obese |
6.349000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.116200E-01 |
| Obese-vs-Extreme_Obese |
8.006000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.205400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.654820E-01 |
| Normal-vs-Age(61-80Yrs) |
1.397830E-02 |
| Normal-vs-Age(81-100Yrs) |
1.446210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.289000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.897430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.501200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.503000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.901400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.243400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.705900E-02 |
| Normal-VS-Type2 PRCC |
1.001810E-01 |
| Normal-VS-KIRP CIMP |
4.508200E-01 |
| Normal-VS-Unclassified PRCC |
1.590950E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.650600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.215590E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.442600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.888000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.682400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.189400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.004600E-01 |
| Normal-vs-N1 |
4.646000E-01 |
| Normal-vs-N2 |
3.615400E-01 |
| N0-vs-N1 |
2.197200E-01 |
| N0-vs-N2 |
7.855600E-01 |
| N1-vs-N2 |
3.568200E-01 |
|
|
